Monte Rosa Therapeutics, Inc. (GLUE)

NASDAQ: GLUE · Real-Time Price · USD

Compare

17.64

+1.16 (7.04%)

At close: Dec 24, 2025, 1:00 PM EST

17.85

+0.21 (1.19%)

After-hours: Dec 24, 2025, 4:40 PM EST

Monte Rosa Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Revenue	181.54	75.62	-	-	-	-	Upgrade
Cost of Revenue	130.57	112.86	103.37	-	-	-	Upgrade
Gross Profit	50.97	-37.24	-103.37	-	-	-	Upgrade
Selling, General & Admin	42.46	43.87	39.94	35.12	15.73	4.01	Upgrade
Research & Development	-	-	-	77.26	57.16	24.01	Upgrade
Operating Expenses	42.46	43.87	39.94	112.38	72.88	28.01	Upgrade
Operating Income	8.51	-81.11	-143.31	-112.38	-72.88	-28.01	Upgrade
Interest & Investment Income	11.85	10.57	9.33	3.76	0.05	0.01	Upgrade
Currency Exchange Gain (Loss)	1.54	0.42	-0.93	0.01	-0.16	-0.2	Upgrade
Other Non Operating Income (Expenses)	-	-	-	-	-0.96	-7.68	Upgrade
EBT Excluding Unusual Items	21.9	-70.13	-134.91	-108.61	-73.96	-35.88	Upgrade
Gain (Loss) on Sale of Investments	-	-	-0.13	-	-	-	Upgrade
Gain (Loss) on Sale of Assets	0.06	-	0.02	0.11	-	-	Upgrade
Pretax Income	21.95	-70.13	-135.01	-108.5	-73.96	-35.88	Upgrade
Income Tax Expense	1.01	2.57	0.34	-	-	-	Upgrade
Net Income	20.95	-72.7	-135.35	-108.5	-73.96	-35.88	Upgrade
Net Income to Common	20.95	-72.7	-135.35	-108.5	-73.96	-35.88	Upgrade
Shares Outstanding (Basic)	82	74	51	47	25	2	Upgrade
Shares Outstanding (Diluted)	83	74	51	47	25	2	Upgrade
Shares Change (YoY)	22.34%	43.80%	8.83%	88.91%	1548.09%	7.11%	Upgrade
EPS (Basic)	0.25	-0.98	-2.63	-2.30	-2.96	-23.65	Upgrade
EPS (Diluted)	0.25	-0.98	-2.63	-2.30	-2.96	-23.65	Upgrade
Free Cash Flow	145.02	38.01	-62.84	-105.38	-69.1	-26.44	Upgrade
Free Cash Flow Per Share	1.75	0.51	-1.22	-2.23	-2.76	-17.43	Upgrade
Gross Margin	28.08%	-49.25%	-	-	-	-	Upgrade
Operating Margin	4.69%	-107.26%	-	-	-	-	Upgrade
Profit Margin	11.54%	-96.14%	-	-	-	-	Upgrade
Free Cash Flow Margin	79.88%	50.26%	-	-	-	-	Upgrade
EBITDA	16.84	-72.99	-137.09	-108.64	-70.75	-27.47	Upgrade
EBITDA Margin	9.28%	-96.52%	-	-	-	-	Upgrade
D&A For EBITDA	8.33	8.12	6.22	3.75	2.13	0.54	Upgrade
EBIT	8.51	-81.11	-143.31	-112.38	-72.88	-28.01	Upgrade
EBIT Margin	4.69%	-107.26%	-	-	-	-	Upgrade

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q